|Videos|July 17, 2015

The Finish Line for Provider Status

Stephen F. Eckel, PharmD, MHA, Pharmacy Times Health-System Edition editor, defines what he thinks is the finish line of the provider status movement.

Stephen F. Eckel, PharmD, MHA, Pharmacy Times Health-System Edition editor and associate professor at the Eshelman School of Pharmacy at the University of North Carolina, defines what he thinks is the finish line of the provider status movement.

This video was recorded at APhA's Annual Meeting and Exposition in March 2015.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

The Finish Line for Provider Status

Newsletter

Related Content

Pharmacists Play Key Role in Rapid Induction, Retention for Opioid Use Disorder Treatment

Accelerated Approval of Cancer Drugs: Benefit or Burden?

Distinguishing Primary Ovarian Insufficiency From Natural Menopause

Growing Neighborhood and Socioeconomic Factors Tied to Surge in Childhood Type 2 Diabetes Rates

FDA, HHS Move to Accelerate Biosimilar Approvals

Latest CME

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support Insulin Pump Management

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support Insulin Pump Management (Pharmacy Technician Credit)

The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake

Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Settings

The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non‒Small Cell Lung Cancer

Balancing the Burden of Moderate to Severe Atopic Dermatitis in Pediatric Patients: Navigating the Use of Targeted Biologic Therapies and Caregiver Challenges

Addressing the Unmet Needs in the Management of Myasthenia Gravis: The Role of New and Emerging Therapies

Harnessing the Potential of SGLT2 Inhibitors in Cardiorenal Metabolic Health: Strategies for Long-term Care and Consultant Pharmacists

How Artificial Intelligence Is Transforming Cancer Care: Essential Insights for Oncology Pharmacists

Charting the Course: The Pharmacist's Role in Safeguarding Patients From Immune-Related Adverse Events

The Evolving Treatment Landscape of Migraine

The Role of the Pharmacist Migraine Management

Guiding Bispecific Antibody Use in Non-Hodgkin Lymphoma: Integrating Evidence and Enhancing Care

Navigating the New Wave in Targeted Therapies for Acute Myeloid Leukemia: A Focus on IDH and FLT3 Mutations

Strategies to Reduce Challenges in the Management of Chronic Rhinosinusitis with Nasal Polyps: The Role of Biologic Therapy

Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the Spread of HIV

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

Advancing Care in Metastatic Prostate Cancer Care: Emerging Combination Therapies and Patient-Centered Strategies

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

Demystifying CGM: Addressing Frequently Asked Questions and Key Insights

Improving the Care of Persons Living With Diabetes Using CGM Devices (Pharmacy Technician Credit)

Continuous Glucose Monitoring: What's New in 2025?

Advancing Stroke Prevention: The Pharmacist’s Role in Implementing the 2024 Guidelines

Respiratory Syncytial Virus Disease Prevention in Adults: The Pharmacist’s Role in Improving Vaccine Uptake

Evaluating the Role of Pharmacists in Utilizing Potassium-Competitive Acid Blockers for Acid Peptic Disorders

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases

Balancing Pain Management and Opioid Use Disorder: Recognition, Treatment, and Compassionate Communication in Pharmacy Practice

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Advancing Multiple Sclerosis Treatment: Exploring Evolving Therapies and Patient-Centered Approaches

New and Emerging Therapies for the Management of Narcolepsy: A Guide to Patient-Centered Care

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Exploring ATTR Phenotypes and Identifying Appropriate Opportunities for Pharmacists to Intervene

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

Advances in Castration-Sensitive Prostate Cancer: A Pharmacist's Approach to Optimize Novel Antiandrogen Therapies

Securing the Supply Chain: The Pharmacists’ Role in DSCSA Compliance

Chronic Obstructive Pulmonary Disease and Inflammation: Practical Approaches to Integrating Biologic Therapy

Addressing the Burden of Hemolysis in Paroxysmal Nocturnal Hemoglobinuria: The Pharmacist's Contribution to Patient Care

Payment for Pharmacist Services: 2025 Update

Combating Opioid Overdoses: The Impact of Pharmacist-led Counseling and Dispensing of Opioid Reversal Agents

New and Approved: FDA’s 2024 Drug Lineup

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia

Navigating Adverse Effects in HR+/HER2-Negative Metastatic Breast Cancer: Tailored Management Plans and Pharmacist Interventions for Improved Outcomes

Innovations in Lymphoma Treatment and the Growing Impact of Bispecific Antibodies

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

In-Depth Insights and Application in the Management of Immunoglobulin Therapy

Revolutionizing Acute Pain Relief: Emerging Non-Opioid Therapies and the Essential Role of Pharmacists

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

Optimizing Treatment Strategies: A Comprehensive Approach to Primary Biliary Cholangitis and Pruritus

New and Approved: FDA’s 2024 Drug Lineup (Pharmacy Technician Credit)

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technician Credit)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)

Hyperlipidemia Overview and the Clinical and Economic Burden

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

An Evolving Treatment Paradigm: Innovative Approaches and Critical Insights in the Management of Newly Diagnosed Multiple Myeloma

Transforming Lymphoma Treatment With Bispecific Antibodies: Practical Solutions for Oncology Pharmacy Teams

Maximizing Safety With Antibody-Drug Conjugates: Essential Practices for HER2, Trop-2, and HER3 Treatments

Streamlining Pharmacist-Led Hyperglycemia Management in HR+ Breast Cancer: Overcoming PI3K/AKT Inhibitor Challenges

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management